MindBio Therapeutics Corp.
MindBio Therapeutics Corp. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.
Recent Articles:
MindBio Therapeutics Advances Voice AI Kiosk for Intoxication Detection Toward Commercial Pilot
MindBio Therapeutics Positions Voice AI Kiosks for Growth in Workplace Safety Markets
MindBio Therapeutics Advances AI Voice Tech for Workplace Safety in Growing Biotech and AI Detector Markets
MindBio Therapeutics Positions Voice AI Technology for Growth in Safety-Critical Sectors
Biotech Firm Launches Massive AI Safety Solution for Zero-Tolerance Industries
Biotech Firm Deploys Revolutionary Intox AI, Unlocking Billion-Dollar Industrial Safety Opportunity
More Articles
Experts Following This Company
| Stewart Thomson – Thomson Research |
Important Disclosures
MindBio Therapeutics Corp. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases.
The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content.
Billboard advertising monthly fees range from $3,000 to $5,000.
This landing page contains a summary of the company that was prepared by that company.
Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company.
The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports.
There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page.
Readers should conduct their own research for all information publicly available concerning the company.
This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.
Streetwise Company Fact Sheet2026/10/20 16:33:02
(MBIO:CSE - MBQIF:OTCQB - WF6:FSE)
Technical Market Strategist
| Thomson Research — Stewart Thomson |
Company News
| View Latest News |
Streetwise Reports Articles
| 10/20/2026 - View Article |
| 06/13/2026 - View Article |
| 06/12/2026 - View Article |
| 06/12/2026 - View Article |
| 06/11/2026 - View Article |
Streetwise - MindBio Therapeutics Corp. Ownership Overview*
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:FSE)
| Strike Price | Number | Expiry Date |
|---|---|---|
| $0.8 | 2,506,071 | 11/01/28 |
| Date | Old Symbol | Old Shares | New Symbol | New Shares |
|---|---|---|---|---|
| 11/06/25 | MBIO:NASDAQ | 400 | MBIO:NASDAQ | 1 |
| MindBio uniquely uses the human voice as a diagnostic tool for screening drug and alcohol intoxication | |
| It is at the forefront of AI and speech analytics in this regard being commercially ready with its Booze AI consumer product and the Q2 launch of its Edge AI Enterprise Kiosks for deployment in the mining industry. | |
| Expected Q2 2026 testing of Edge AI Kiosks in mining industry, currently in development | |
| Tight capital structure, only 4.7mill shares on issue, pre the current raise, post raise under 6 million shares on issue |
 Q1 2026 |
Completion of new data collection and analysis technology, now.
|
 Q2 2026 |
First testing of Edge AI Intox Detection Kiosks in mining industry Q2. 2026
|
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
